Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

J&J to buy eye disease biotech Ollin Biosciences for up to $3.3B

Johnson & Johnson said Monday it will snap up Ollin Biosciences in a deal worth up to $3.3 billion, just a little over a year after the ophthalmology biotech broke cover ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

Can Robots Bring Stroke Surgery to Remote Hospitals?

I am practicing brain surgery on a patient lying 6 meters away, out of my sight and reach. I press a foot pedal, activating the controller in my hand, and carefully steer a thin flexible tube called a catheter up through the patient’s blood vessels. I head for what I believe to be the brain, tracking my progress on the live X-ray feed.

More from Monday 16 November →